Dr. Karan P. Singh has been elected to the National Cancer Institute’s Gynecologic Cancer Steering Committee (GCSC).

The GCSC is one of the National Clinical Trials Network Disease-Specific Steering Committees of the Coordinating Center for Clinical Trials. According to the mission statement on their website, “The GCSC functions to harmonize an efficient, cost-effective, science-driven, and transparent process that will identify and promote the ‘Best Science’ in gynecologic cancer clinical research by addressing the design and prioritization of phase 3 trials and evaluating randomized phase 2 studies. As part of its mission, this GCSC is intent on fostering collaboration with international groups and institutions engaged in conducting trials in gynecologic cancers.” Dr. Singh is honored to be part of such an important part of the NCI’s strategy in fighting cancer.